High-Value Diagnostics

Training Courses

|
Media
|

Keynote Speakers

Ellen Beasley Senior Vice President, Genomic Health Inc	Xandra Breakefield Professor, Mass General Hospital (MGH)/Harvard Medical School	Raghu Kalluri Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center	Walter Koch Vice President, Roche Molecular Systems	Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands	Lawrence Rajendran Velux Stiftung Professor for Systems and Cell Biology of Neurodegeneration, University of Zurich
Lynn Sorbara Program Director, National Cancer Institute	Kendall Van Keuren-Jensen Professor and Deputy Director, Translational Genomics Research Institute	David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Overview

The 2^nd Annual Biofluid Biopsies and High Value Diagnostics 2015 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.

We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks.

All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities.

Present Your Research at this Conference in a Poster to a Worldwide Audience. Poster Submission Deadline: November 2, 2015

Agenda Topics

Circulating Tumor Cells (CTCs): Potential for Development of Biofluid-based Biopsies
Circulating Tumor DNA (ctDNA): Potential for Development of Biofluid-based Biopsies
Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNA and Their Use to Develop Diagnostics
Extracellular Vesicles (EVs): Potential for Development of Biofluid-based Biopsies
Potential of microRNAs as Biomarkers for Diagnostics Development and as Companion Diagnostics
US vs. EU vs. Asia/Pacific Regulatory Landscape for Novel High-Value Diagnostics

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Louise Laurent, Associate Professor, University of California-San Diego
Malini Harigopal, Associate Professor, Dept of Pathology, Breast and Cytopathology, Yale University
Klaus Lücke, CEO & Founder, GILUPI GmbH
Y. Peng Loh, Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH)
Johan Skog, Chief Scientific Officer, Exosome Diagnostics Inc
Lyle Arnold, Chief Scientific Officer, Biocept
Sandra Gaston, Director, Molecular Biomarkers Research Laboratory; Scientific Director, Tufts Medical Center Biorepository, Tufts Medical Center
Cloud Paweletz, Head of the Translational Research Laboratory, Dana Farber Cancer Institute
Clifford Librach, Medical and Scientific Director, CReATe Fertility Centre
Dolores Di Vizio, Professor, Cedars Sinai Medical Center
Mike Makrigiorgos, Professor, Dana-Farber Cancer Institute/Harvard Medical School
Ruth Katz, Professor of Pathology, Chief Image Analysis Laboratory, Chief Research Cytopathology, MD Anderson Cancer Center
Winston Patrick Kuo, SAB, Exosomics Siena; Editor-in-Chief, Journal of Circulating Biomarkers, InTech Publishers
Shlomit Kenigsberg, Senior Researcher, Create Fertility Centre
Susan Magdaleno, Sr. Manager, R&D, Thermo Fisher Scientific

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking